TCR² Therapeutics Inc.
Developing T cell therapies
- B2B
About TCR² Therapeutics Inc.
Clinical-stage cell therapy company developing novel T cell therapies targeting solid tumors by utilizing TCR Fusion Construct T cells to kill cancer cells
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- Cambridge, Massachusetts, United States
- Founded
- 2015
- Revenue
- $12.1M – $95.4MTamtam estimate
- Website
- tcr2.com
- linkedin.com/company/tcr2-inc-
TCR² Therapeutics Inc. at a glance
TCR² Therapeutics Inc. is a B2B company in the Biotechnology Research industry, headquartered in Cambridge, Massachusetts, United States.
TCR² Therapeutics Inc. was founded in 2015.
TCR² Therapeutics Inc. has 51–250 employees.
TCR² Therapeutics Inc.'s revenue is $12.1M – $95.4M (Tamtam estimate).
Selling to companies like TCR² Therapeutics Inc.?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies